Toggle Offcanvas
...
 
Ambrisentan Tenders

Ambrisentan Tenders

View Ambrisentan tenders, RFPs and contracts. Bid on readily available Ambrisentan tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Ambrisentan tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Ambrisentan.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Ambrisentan market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Ambrisentan tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

33 Live Notices for Ambrisentan Tenders

Showing 1 to 20

Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date10 Feb 2025
deadline31 Jan 2027
55Th Generics Tender_Fl
country Germany
posting date05 Feb 2025
deadline17 Mar 2025
Prescription Service Drug Insurance Supplement Competition
country Saudi Arabia
posting date30 Jan 2025
deadline03 Nov 2025
Drugs (In 16 Batches)
country Spain
posting date20 Jan 2025
deadline19 Feb 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Ambrisentan (Atc Code According To Who: C02Kx02)
country Germany
posting date21 Nov 2024
deadline31 Jan 2027

Share Share this page